A CD4+ count below 200 cells/μL, advanced age at antiretroviral therapy initiation, and protease inhibitor use were associated with low-level viremia and increased risk for virologic failure among ...

Most women living with HIV achieved an immunologic response after 2 years of initiating antiretroviral therapy. A higher baseline HIV viral load increased the odds of an immunologic response in women ...

Reviewed by Carrie D. Johnston, MD, MS, Assistant Professor in the Division of Infectious Diseases at Weill Cornell Medical College in New York City. "Medical Journeys" is a set of clinical resources ...

According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million people living with HIV in the United States, and another 1.2 to 2.2 ...

In all likelihood, this patient was more adherent to her antiretroviral drug regimen during the period before January 2004 as compared with the period before January 2003. Otherwise, the improvements ...

A new paper in Molecular Biology and Evolution, published by Oxford University Press, finds that HIV populations in people with higher viral loads also have higher rates of viral recombination. In ...

A review found that CD4/CD8 ratio could be used as a prognostic marker for mortality in patients with HIV, though future studies need to be done to confirm these findings. Clinical practices can ...

Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting ...

Evidence shows almost zero risk of sexual transmission when HIV viral loads are less than 1000 copies/mL, which could allow providers to destigmatize HIV and promote antiretroviral therapy adherence.

A federally funded clinical trial suggests knowing HIV viral load (number of HIV particles in the body) doesn’t improve the number of patients seeking treatment for active HIV infection or preventive ...